| Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. | |
| | |
MedLine Citation:
|
PMID: 20437113 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF). The current recommendation for pharmacological treatment of this condition is amiodarone. A review of the past 25 years of literature finds several studies that identify a small risk of ventricular fibrillation secondary to amiodarone administration for rate control in WPW-AF. Additionally, the literature supports the safe and effective use of procainamide for rate control in WPW-AF. This review concludes that amiodarone is not superior to procainamide in rate control for WPW-AF, and may be dangerous. |
| | |
Authors:
|
Sharis M Simonian; Shahram Lotfipour; Christopher Wall; Mark I Langdorf |
Related Documents
:
|
6813963 - Urethritis in men. 2107893 - Methods and basic data of case-control study of leukaemia and lymphoma among young peop... 21129913 - Increasing patient safety event reporting in 2 intensive care units: a prospective inte... |
Publication Detail:
|
Type: Case Reports; Journal Article; Review Date: 2010-05-01 |
Journal Detail:
|
Title: Internal and emergency medicine Volume: 5 ISSN: 1970-9366 ISO Abbreviation: Intern Emerg Med Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-20 Completed Date: 2011-01-24 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101263418 Medline TA: Intern Emerg Med Country: Italy |
Other Details:
|
Languages: eng Pagination: 421-6 Citation Subset: IM |
Affiliation:
|
Department of Emergency Medicine, University of California-Irvine School of Medicine, 101 The City Drive, Orange, CA 92868, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Amiodarone / therapeutic use* Anti-Arrhythmia Agents / therapeutic use* Atrial Fibrillation / diagnosis, drug therapy*, etiology Electrocardiography Emergency Service, Hospital Humans Male Procainamide / therapeutic use* Tachycardia / drug therapy*, etiology Wolff-Parkinson-White Syndrome / complications, drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Arrhythmia Agents; 1951-25-3/Amiodarone; 51-06-9/Procainamide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Rapid urease test for H. pylori diagnosis: pros and cons.
Next Document: Selecting Patients for Epilepsy Surgery.